ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants

September 29, 1978

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

ACS Asks Higher NCI Authorization

March 24, 1978

Preliminary Action Plan Seeks Consumer Representation

January 7, 1994

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

January 23, 1976

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001